Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
BELLINGS Intelligence Score: 10
Why it matters
This is a routine comparative analysis of two healthcare ETFs with no direct impact on credit markets, regulation, or monetary policy, thus of limited significance to sophisticated credit professionals.